Lab21 appoints group director


Of quality, regulatory affairs and operations excellence

Lab21, a global specialist in personalised medicine and clinical diagnostics, has appointed Fraser Logue as group director of quality, regulatory affairs and operations excellence based Cambridge in the UK.

Dr Logue worked for almost two decades in divisions of Abbott Laboratories. He was most recently division vice president World Wide Manufacturing for Abbott Diabetes Care, moving from division vice president European Operations. Prior to this he was operations director for Abbott Diagnostics Division Ireland, and director of Quality & Regulatory and marketing manager for Abbott Diagnostics Division in Germany.

Dr Logue said: ‘Lab21 has achieved remarkable progress within the past 4 years, growing five times in size. I am looking forward to contributing to its future success.’